颅内动脉钙化作为后续主要不良心血管事件的预后因素
该回顾性研究纳入175例年龄>60岁、因轻微外伤或神经系统疾病行头颅平扫CT的连续患者,用半定量钙化斑块评分(CPS)评估7条颅内动脉的ICAC,随访平均39.8±7.8个月。随访期间发生36例MACE(年事件率6.2%/年),MACE患者平均CPS显著高于无MACE者(p<0.01);CPS<5组无MACE生存和总生存均显著长于CPS≥5组(p<0.01)。结论认为ICAC患者未来心脑血管事件风险增加,ICAC可能是评估老年患者此类事件风险的预后因素。
要点
- 头颅平扫CT发现颅内动脉钙化时,可用半定量钙化斑块评分(CPS)评估7条颅内动脉。
- CPS≥5的高斑块负荷患者无MACE生存和总生存均显著短于CPS<5者(p<0.01)。
- CPS为0的15例患者随访期间均未发生MACE。
核心结论
- ICAC患者未来发生心脑血管事件的风险增加,ICAC可能是确定老年患者这些事件风险的预后因素。
研究设计与样本
- 回顾性、经IRB批准的研究,纳入175例年龄>60岁的连续患者(89例男性,平均年龄78.3±8.5岁),因轻微外伤或神经系统疾病行头颅平扫CT;采用半定量量表评估7条颅内动脉的ICAC并得出钙化斑块评分(CPS);通过问卷和电话访谈获取临床随访信息。
关键影像表现/征象
- 在7条颅内动脉上检测ICAC,使用半定量量表计算钙化斑块评分(CPS)。
- CPS为0的患者共15例,随访期间无一例发生MACE。
诊断标准与关键数值
- MACE定义为心肌梗死或血运重建、卒中或心血管事件导致的死亡。
- 以CPS<5为低斑块负荷、CPS≥5为高斑块负荷进行分组比较。
- 随访期间共发生36例MACE,年事件率为6.2%/年。
- MACE患者随访期间平均CPS显著高于无MACE者(p<0.01)。
- CPS<5组无MACE生存和总生存均显著长于CPS≥5组(p<0.01)。
临床应用与阅片要点
- 原文结论认为ICAC患者未来心脑血管事件风险增加,ICAC可能是确定老年患者这些事件风险的预后因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Intracranial arterial calcifications (ICAC) are often detected on unenhanced CT of patients with an age > 60. However, association with the subsequent occurrence of major adverse cardiovascular events (MACE) has not yet been evaluated.
PURPOSE: This study aimed at evaluating the association of ICAC with subsequent MACE and overall mortality.
METHODS: In this retrospective, IRB approved study, we included 175 consecutive patients (89 males, mean age 78.3 ± 8.5 years) of age > 60 years who underwent an unenhanced CT of the head due to minor trauma or neurological disorders. Presence of ICAC was determined in seven intracranial arteries using a semi-quantitative scale, which resulted in the calcified plaque score (CPS). Clinical follow-up information was obtained by questionnaires and telephone interviews. MACE was defined as myocardial infarction or revascularization, stroke or death due to cardiovascular event.
RESULTS: Mean follow-up time was 39.8 ± 7.8 months, resulting in 579.7 patient-years of follow-up. Overall, 36 MACE occurred during follow-up (annual event rate = 6.2%/year). Mean CPS was significantly higher in subjects with MACE during follow-up compared to subjects without MACE (p < 0.01). In 15 patients CPS was 0; in none of these patients MACE was registered. Kaplan-Meier-analysis revealed that patients with a low plaque burden (CPS < 5) had a significant longer MACE-free and overall survival than patients with a high plaque burden (CPS ≥ 5) (p < 0.01).
CONCLUSION: Patients with ICAC have an increased risk for future cardio- or cerebrovascular events. Therefore, ICAC might be a prognostic factor to determine the risk for these events in older patients.
引用
- Strobl FF, Kuhlin B, Stahl R, et al. Intracranial arterial calcifications as a prognostic factor for subsequent major adverse cardiovascular events (MACE). Radiol Med. 2018. PMID: 29380261. doi:10.1007/s11547-018-0856-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。